| APC |
Tumor Suppressor Gene |
Truncating
Mutation (e.g., Nonsense, Frameshift) |
Underexpressed |
Wnt/β-catenin pathway |
Loss of APC leads
to uncontrolled cell growth, as it fails
to regulate β-catenin levels in the cell, resulting in increased
cell proliferation. |
(20) |
| KRAS |
Oncogene |
Point Mutation (e.g., G12D, G13A) |
Overexpressed |
MAPK Signaling Pathway |
Mutations in KRAS lead to constitutive activation of the MAPK
pathway, promoting uncontrolled cell proliferation and survival. |
(21) |
| TP53 |
Tumor Suppressor Gene |
Various Mutations (e.g., Missense, Nonsense, Frameshift) |
Underexpressed |
Cell Cycle Regulation |
Loss of TP53 function allows for the unchecked growth of damaged
cells, increasing the risk of tumorigenesis. |
(22) |
| SMAD4 |
Tumor Suppressor Gene |
Deletion,
Missense, Nonsense, Frameshift |
Underexpressed |
TGF-β Signaling Pathway |
Loss of SMAD4 disrupts
the regulation of cell differentiation
and growth in the TGF-β pathway, contributing to cancer development. |
(23) |
| BRAF |
Oncogene |
Point Mutation
(e.g., V600E) |
Overexpressed |
MAPK Signaling
Pathway |
Mutations in BRAF, such as V600E, lead to overactive
MAPK signaling,
driving uncontrolled cell division and tumor growth. |
(24) |
| PIK3CA |
Oncogene |
Point Mutation
(e.g., H1047R) |
Overexpressed |
PI3K/Akt
Signaling Pathway |
Mutations in PIK3CA enhance PI3K/Akt
signaling, promoting cell
survival and growth through the activation of downstream effectors. |
(25) |
| PTEN |
Tumor Suppressor Gene |
Deletion, Missense, Nonsense, Frameshift |
Underexpressed |
PI3K/Akt Signaling Pathway |
Loss of PTEN results
in increased PI3K/Akt signaling, leading
to enhanced cell survival and growth, and contributing to carcinogenesis. |
(26) |